Growing prevalence of urological disorders and minimally invasive treatment adoption is projected to drive the growth of the global urology devices market at a CAGR of 3.94% during the forecast period of 2025–2035.

Technological Advancements and Growing Aging Population to Drive the Global Urology Devices Market at a CAGR of 22.20% during the Forecast Period 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “Global Urology Devices Market” that contains information from 2025 to 2035. The Urology Devices market is estimated to register a CAGR of 22.20% during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the Global Urology Devices Market — Smith and Nephew, UroLift, Coloplast, Baxter International, Cook Medical, Fresenius Medical Care, Johnson & Johnson, ConvaTec, Stryker, Olympus Corporation, Teleflex, Medtronic, Merit Medical Systems, Boston Scientific, and Asahi Kasei Corporation.

Market Highlights

The Global Urology Devices Market is accounted for to register a CAGR of 22.20% during the forecast period and is estimated to reach USD 420.90 billion by 2035.

The market is growing mainly because more people are getting urological disorders, technology is getting better, and the population is getting older. More people are becoming aware of their urological health, and more people are choosing minimally invasive and robotic-assisted surgeries. These are two major trends that are changing the global urology landscape. Telehealth technologies and AI-powered diagnostic tools are also changing the way patients are monitored, consulted, and treated.

The market is growing even faster because the government is giving more money to healthcare infrastructure, more people are getting screened, and there are programs that encourage early diagnosis. For example, in the last five years, the number of people who have participated in global screenings has gone up by almost 15%. This is because more people are aware of the issue and can get better urology care.

The industry is dedicated to innovation, as shown by Medtronic's robotic-assisted surgical systems and Boston Scientific's introduction of minimally invasive urology treatment technologies. Teleflex bought a top urology device company in 2023, which helped it reach more customers. Coloplast bought an innovative device maker, which helped it build up its product line.

Segment Analysis

The Global Urology Devices Market has been segmented based on Product Type, Application, End User, Distribution Channel, and Region.

The Product Type segment is further bifurcated into Endoscopy Devices, Lithotripters, Dialysis Equipment, Prostate Devices, and Catheters. Among these, the Endoscopy Devices segment dominated the market in 2024 with a valuation of USD 2.0 billion and is projected to reach USD 3.2 billion by 2035. These devices are critical for minimally invasive diagnostic procedures, offering enhanced precision and reduced recovery time. The Dialysis Equipment segment also holds a considerable share, valued at USD 1.5 billion in 2024, expected to reach USD 2.5 billion by 2035, driven by the growing prevalence of chronic kidney diseases.

The Application segment is further categorized into Diagnosis, Therapy, and Surgery. The Surgery segment accounted for a significant market share in 2024, owing to the rising adoption of robotic-assisted and minimally invasive procedures, which reduce patient recovery time and hospital stay. Meanwhile, the Diagnosis segment continues to expand due to the increasing use of advanced imaging and screening technologies for early detection of urological conditions.

The End User segment is further divided into Hospitals, Clinics, and Home Care Settings. Among these, the Hospitals segment held the largest share in 2024, driven by the availability of advanced infrastructure and the rising number of surgical procedures. The Home Care segment is also gaining traction, supported by technological developments that enable remote monitoring and patient comfort.

The Distribution Channel segment is further segmented into Direct Sales, Distributors, and Online Sales. Direct Sales accounted for a major share in 2024 due to their ability to offer personalized services and faster support to healthcare providers. Meanwhile, Online Sales are witnessing notable growth, offering easier access to medical devices for both professionals and end users.

Region Analysis

By Region, the Urology Devices Market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

The North America Urology Devices Market held the largest market share in 2024, valued at USD 3.0 billion, and is projected to reach USD 4.5 billion by 2035. This dominance is attributed to technological advancements, high healthcare expenditure, and the presence of major industry players such as Johnson & Johnson, Stryker, and Boston Scientific. The region’s strong focus on innovation and early adoption of robotic-assisted surgery further fuels market growth.

Key Findings of the Study

• The Global Urology Devices Market is expected to reach USD 420.90 billion by 2035, at a CAGR of 22.20% during the forecast period.


• North America accounted for the largest market share in 2024, valued at USD 3.0 billion, and is projected to reach USD 4.5 billion by 2035.


• Asia Pacific is expected to be the fastest-growing market during the forecast period.


• Based on Product Type, the Endoscopy Devices segment dominated the market in 2024.


• Based on the Application, the Surgery segment accounted for a significant market share in 2024.


• Smith and Nephew, UroLift, Coloplast, Baxter International, Cook Medical, Fresenius Medical Care, Johnson & Johnson, ConvaTec, Stryker, Olympus Corporation, Teleflex, Medtronic, Merit Medical Systems, Boston Scientific, and Asahi Kasei Corporation are identified as the key market players.

Related Reports